Adar Poonawalla thinks a vaccine that requires ultra cold storage should not be considered as a good vaccine. (Photo: HT)

‘A good vaccine is…’: Adar Poonawalla’s cryptic tweet has many targets

Moderna and Pfizer’s announcement of the security proportion of their vaccine candidate has intensified the vaccine battle. Serum Institute of India’s CEo Adar Poonawalla on Tuesday took to Twitter and reminded {that a} good vaccine is probably not the one which comes first. An excellent vaccine has 4 attributes, Poonawalla tweeted. It needs to be secure, it ought to provide long-term safety in opposition to the targetted illness, it ought to be transported and saved at a manageable temperature. And lastly, it ought to be reasonably priced to all of humanity, Poonawalla wrote.


Latest to the continued vaccine developments, Pfizer and BioNTech SE final week mentioned their vaccine candidate was discovered to be greater than 90 per cent efficient in stopping Covid-19. Moderna on Monday mentioned its vaccine candidate in opposition to Covid-19, discovered it to have an efficacy of 94.5 per cent. The vaccines are at current ready for the approval of the regulatory physique. However, medical specialists usually are not certain whether or not Pfizer vaccine could be useful to poorer nations because the vaccine shot wants minus 70 levels Celsius temperature. In regular medical fridge temperature, Pfizer vaccine might be saved for 5 days.

Major hospitals within the United States have mentioned they don’t have the storage facility as required for Pfizer vaccine. Without taking any title, Poonawalla indicated {that a} good vaccine can’t be so tough to retailer. Earlier, the CEO of the world’s largest vaccine producer — by the quantity — had mentioned to the Washington Post that vaccines that require ultra-cold storage are ‘joke’. “Nobody wants a vaccine that is only going to protect you for a few months,” he had mentioned.

Serum Institute had earlier mentioned that their vaccine will probably be priced at Rs 224 per dose.